Extendicare Inc. (TSE:EXE – Get Free Report) shares crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of C$18.31 and traded as high as C$24.88. Extendicare shares last traded at C$24.55, with a volume of 1,167,487 shares trading hands.
Wall Street Analyst Weigh In
Several brokerages recently commented on EXE. BMO Capital Markets raised Extendicare from a “hold” rating to an “outperform” rating and boosted their price target for the company from C$21.00 to C$24.00 in a research note on Thursday, December 4th. Royal Bank Of Canada raised shares of Extendicare from a “hold” rating to a “moderate buy” rating and boosted their target price for the stock from C$15.00 to C$25.00 in a research report on Thursday, December 4th. Canadian Imperial Bank of Commerce increased their price target on shares of Extendicare from C$18.00 to C$22.00 in a research note on Thursday, November 13th. TD Securities raised their price objective on Extendicare from C$15.00 to C$19.00 in a research note on Thursday, November 13th. Finally, Canaccord Genuity Group raised their price target on Extendicare from C$20.00 to C$22.50 in a research report on Thursday, December 4th. One research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and one has given a Hold rating to the company’s stock. Based on data from MarketBeat.com, Extendicare presently has a consensus rating of “Buy” and a consensus target price of C$24.50.
Get Our Latest Research Report on Extendicare
Extendicare Stock Performance
About Extendicare
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.
Recommended Stories
- Five stocks we like better than Extendicare
- Unlocked: Elon Musk’s Next Big IPO
- Buy This Stock Now
- America’s 1776 happening again
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.
